Aridis Pharmaceuticals Inc.

Historical 13F Holders

Symbol
ARDS
CUSIP
040334104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 040334104 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 9
11.4% 8/14/2026
Event 6/30/2026
Armistice Capital, LLC 13G/A Amendment 8
11.4% 5/15/2026
Event 3/31/2026
Armistice Capital, LLC 13G/A Amendment 7
11.4% 2/17/2026
Event 12/31/2025
Armistice Capital, LLC 13G/A Amendment 1
9.5% 2/17/2026
Event 12/31/2025
Armistice Capital, LLC 13G/A Amendment 5
11.4% 8/14/2025
Event 6/30/2025
Armistice Capital, LLC 13G
6.6% 8/14/2025
Event 6/30/2025
Armistice Capital, LLC 13G/A Amendment 4
11.4% 5/15/2025
Event 3/31/2025
Armistice Capital, LLC 13G/A Amendment 3
11.4% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 3.00 k $0
2026 Q1 1 3.00 k $1.00
2025 Q3 1 3.00 k $3.00
2023 Q4 2 300 $10.00
2023 Q3 1 14.1 k $1.44 k
2023 Q2 20 1.78 M $392 k
2023 Q1 22 4.13 M $1.29 M
2022 Q4 19 3.93 M $4.63 M
2022 Q3 18 1.93 M $1.79 M
2022 Q2 22 1.87 M $2.05 M
2022 Q1 24 1.92 M $3.38 M
2021 Q4 27 1.32 M $3.08 M
2021 Q3 19 1.99 M $7.33 M
2021 Q2 14 1.08 M $7.87 M
2021 Q1 13 1.01 M $6.22 M
2020 Q4 12 741 k $4.50 M
2020 Q3 9 183 k $1.29 M
2020 Q2 9 107 k $711 k
2020 Q1 8 96.4 k $556 k
2019 Q4 7 92.5 k $411 k
2019 Q3 8 111 k $747 k
2019 Q2 7 47.0 k $477 k
2019 Q1 7 58.4 k $642 k
2018 Q4 5 14.6 k $161 k
2018 Q3 7 55.7 k $725 k